Board of Directors and India Leadership Team
Our Board and India Leadership Team (ILT) have overall responsibility for delivering our ambition, strategy and culture.
Board of Directors
Leadership team
Bhushan Akshikar
Managing Director
Juby Chandy
Chief Financial Officer
Harsh Trehan
Executive Vice President, Human Resources
Sharmishta Mitra
Vice President, Paediatric Vaccines
Carson Dalton
Executive Vice President, Communications and Government Affairs
Ajay Nadkarni
Vice President, Real Estate, Administration and Company Secretary
Sukanya Choudhury
Executive Vice President, Regulatory Affairs
Dr. Shalini Menon
Executive Vice President, Medical Affairs
Amit Pandey
Executive Vice President, Legal
Dr. Simrat Sohal
Vice President, Ethics and Compliance
Omkar Parnandiwar
Vice President, Adult Vaccines
Aparajita Rajput
Vice President, Technology
Vibhuti Gupta
Vice President, Commercial Operations and Strategy
Rishikesh S. Jaiwant
Executive Vice President, Supply Chain Operations
Vishwanath Swarup
Vice President, General Medicines
Governance

ANNUAL REPORT 2024-2025
In this report, we have included statements that anticipate our future performance based on past experience and reasonable assumptions. However, we want to emphasise that these statements are subject to change based on various factors such as changes in industry trends, market conditions, government regulations, laws, and other unforeseen circumstances. It is important to note that these forward looking statements are not a guarantee of our future performance, as the underlying assumptions may change significantly over time. Therefore, we advise readers to exercise caution when relying on these statements and to consider them as indicative of potential outcomes rather than definitive predictions.
At GSK, we are committed to operating at the highest standards of corporate governance.
We believe our governance structure underpins our ability to deliver the company's strategy to grow a diversified business, deliver more products of value and simplify the operating model.
This section provides information on how GSK is governed, including details on our Board Committees, shareholder information and services, global compliance and ethical conduct.
Board Committees and Membership
Audit Committee | ||
Particulars | Designation | Directorship |
Mr. Somasundaram PR | Chairman | Independent Director |
Ms. R.S. Karnad | Member | Non- Executive Director |
Mr. M. Anand | Member | Independent Director |
Mr. A. Nadkarni | Company Secretary |
Risk Management Committee | ||
Particulars | Designation | Directorship |
Mr. Somasundaram PR | Chairman | Independent Director |
Ms. R.S. Karnad | Member | Non- Executive Director |
Mr. M. Anand | Member | Independent Director |
Mr. A. Nadkarni | Company Secretary |
Nomination & Remuneration Committee | ||
Particulars | Designation | Directorship |
Mr. M. Anand | Chairman | Independent Director |
Ms. R.S. Karnad | Member | Non- Executive Director |
Mr. A. Wadhawan | Member | Independent Director |
Mr. A. Nadkarni | Company Secretary |
Stakeholder Relationship Committee | ||
Particulars | Designation | Directorship |
Ms. R.S. Karnad | Chairman | Non- Executive Director |
Dr. S. Maheshwari | Member | Independent Director |
Mr. B. Akshikar | Member | Executive Director |
Mr. A. Nadkarni | Company Secretary |
Corporate Social Responsibility Committee | ||
Particulars | Designation | Directorship |
Dr. S. Maheshwari | Chairman | Independent Director |
Mr. A. Wadhawan | Member | Independent Director |
Mr. B. Akshikar | Member | Executive Director |
Mr. A. Nadkarni | Company Secretary |